You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
30 June 2026 - Zelluna ASA (OSE:ZLNA), a Norway-based company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cells for the treatment of cancer, said on Tuesday that it has been awarded a NOK16m grant by ...
30 June 2026 - Anixa Biosciences, Inc. (NASDAQ: ANIX), a California-based biotechnology company involved in the treatment and prevention of cancer, announced on Monday that the Korean Ministry of Intellectual Property (MOIP) has issued Patent Number ...
30 June 2026 - Nuvation Bio (NYSE: NUVB), a New York-based global oncology company involved in cancer treatment, announced on Monday that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom (UK) has validated the Mark...
30 June 2026 - Grünenthal, a Germany-based pharmaceutical company, announced on Monday that the company has successfully concluded a Phase I trial evaluating the safety and tolerability of its proprietary NOP agonist.The company says that in the...
29 June 2026 - Cell-free DNA and precision medicine company Natera Inc (NASDAQ: NTRA) and Aveta Biomics Inc, a clinical-stage immuno-oncology company, on Monday announced a strategic partnership to support Aveta's global Phase 3 registrational t...
29 June 2026 - Biotechnology company United Therapeutics Corporation (Nasdaq: UTHR) announced on Monday that it has received U.S. Food and Drug Administration premarket approval for the LungFX device, the first system approved for centralised ex vivo...
29 June 2026 - US biopharmaceutical company AbbVie (NYSE: ABBV) said on Monday it has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use recommending approval of upadacitinib for adult...